Global Patent Index - EP 1165060 A4

EP 1165060 A4 20020612 - TREATMENT OF GALLSTONES

Title (en)

TREATMENT OF GALLSTONES

Title (de)

BEHANDLUNG VON GALLENSTEINEN

Title (fr)

TRAITEMENT DES CALCULS BILIAIRES

Publication

EP 1165060 A4 20020612 (EN)

Application

EP 00919462 A 20000317

Priority

  • US 0007199 W 20000317
  • US 12560999 P 19990319

Abstract (en)

[origin: WO0056316A1] A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example <u>N</u>,<u>N</u>-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating gallstones, particulary gallstones associated with weight loss or associated with gall bladder disease related to obesity.

IPC 1-7

A61K 31/135; A61K 31/137; A61P 1/16

IPC 8 full level

A61P 1/16 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01)

CPC (source: EP)

A61K 31/137 (2013.01); A61P 1/16 (2017.12)

Citation (search report)

  • [XD] WO 9006110 A1 19900614 - BOOTS CO PLC [GB]
  • [X] WO 9638134 A1 19961205 - KNOLL AG [DE], et al
  • [A] BRAY G A: "Uses and misuses of the new pharmacotherapy of obesity", ANNALS OF MEDICINE, vol. 31, no. 1, February 1999 (1999-02-01), pages 1 - 3, XP001068888
  • See references of WO 0056316A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0056316 A1 20000928; WO 0056316 A8 20010412; AU 4014800 A 20001009; CA 2368416 A1 20000928; EP 1165060 A1 20020102; EP 1165060 A4 20020612; JP 2002539252 A 20021119; MX PA01009462 A 20040319

DOCDB simple family (application)

US 0007199 W 20000317; AU 4014800 A 20000317; CA 2368416 A 20000317; EP 00919462 A 20000317; JP 2000606221 A 20000317; MX PA01009462 A 20000317